Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.17 +0.42 (+1.06%)
As of: Oct 21, 2026 · 12:50 PM EDT

Edgewise Therapeutics (EWTX) Asset Utilization Ratio (2024 - 2026)

Updated

Analysis

Edgewise Therapeutics (EWTX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 0.62
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 0.49
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 0.47
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 0.52
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 0.46
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 0.51
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 0.40
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 0.58
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 0.31
10 Edgewise Therapeutics 4.32 Bn 2.74 Bn - 0.04
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.04
Sep 30, 2025 0.04
Jun 30, 2025 0.04
Mar 31, 2025 0.05
Dec 31, 2024 0.05
API Access

Edgewise Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EWTX&period=max&api_key=YOUR_API_KEY